Incorporated in 2009, Biolidics Limited (“Biolidics” or the
“Company” and together with its subsidiaries the “Group”)
focuses on developing a portfolio of innovative diagnostic
solutions to lower healthcare costs and improve clinical outcomes.
To diversify our business model and build long term growth, the
Group is also actively exploring technology-enabled lifestyle
businesses, which would involve the ownership, operation and
management of Multi-Channel Networks (“MCN”) businesses,
live streaming social e-commerce platforms and Esports-related
businesses.